Chronic Lymphocytic Leukemia News and Research

RSS
Chronic Lymphocytic Leukemia (CLL) is the most common form of leukemia in adults. According to the American Cancer Society, approximately 8,000 patients will be diagnosed this year. More than 60,000 people in the U.S. currently have CLL. The disease arises in lymphocytes, a type of white blood cell that normally produces antibodies and serves important immune functions.
New Blood Cancer Healing Center poised to redefine care standards

New Blood Cancer Healing Center poised to redefine care standards

Combination treatments reduce blood pressure in patients taking ibrutinib

Combination treatments reduce blood pressure in patients taking ibrutinib

Next-gen BTK degrader could help overcome treatment resistance in chronic lymphocytic leukemia

Next-gen BTK degrader could help overcome treatment resistance in chronic lymphocytic leukemia

Cord blood-derived CAR NK cell therapy targeting CD19 shows promise for treating patients with B-cell malignancies

Cord blood-derived CAR NK cell therapy targeting CD19 shows promise for treating patients with B-cell malignancies

Personalized treatment for leukemia results in longer life and fewer side effects

Personalized treatment for leukemia results in longer life and fewer side effects

Targeted drug may offer a new treatment option for patients with relapsed blood cancer

Targeted drug may offer a new treatment option for patients with relapsed blood cancer

As covid infections rise, nursing homes are still waiting for vaccines

As covid infections rise, nursing homes are still waiting for vaccines

Annual NCCN Congress to focus on latest advances in blood cancer treatment

Annual NCCN Congress to focus on latest advances in blood cancer treatment

NCCN publishes new resource on options, benefits of care approaches for pediatric Hodgkin lymphoma

NCCN publishes new resource on options, benefits of care approaches for pediatric Hodgkin lymphoma

Research reveals therapeutic potential of novel compound in inhibiting oncogene translation

Research reveals therapeutic potential of novel compound in inhibiting oncogene translation

Patients with high-risk chronic lymphocytic leukemia may benefit from treatment with ibrutinib plus venetoclax

Patients with high-risk chronic lymphocytic leukemia may benefit from treatment with ibrutinib plus venetoclax

Fred Hutch experts highlight research on cancer treatment advances, survivorship and precision oncology at ASCO

Fred Hutch experts highlight research on cancer treatment advances, survivorship and precision oncology at ASCO

Ultra-processed food and cancer: is there a link?

Ultra-processed food and cancer: is there a link?

Three-drug combination highly effective in patients with high-risk forms of chronic lymphocytic leukemia

Three-drug combination highly effective in patients with high-risk forms of chronic lymphocytic leukemia

Ongoing Phase I clinical trial demonstrates successful re-treatment with CAR T cell therapy

Ongoing Phase I clinical trial demonstrates successful re-treatment with CAR T cell therapy

Whole-genome sequencing reveals five new subgroups of chronic lymphocytic leukemia

Whole-genome sequencing reveals five new subgroups of chronic lymphocytic leukemia

Better physical fitness reduces frailty risk in patients with chronic lymphocytic leukemia

Better physical fitness reduces frailty risk in patients with chronic lymphocytic leukemia

How and when do de novo SARS-CoV-2 spike mutations emerge?

How and when do de novo SARS-CoV-2 spike mutations emerge?

Novel app can help doctors make better decisions for patients with leukemia.

Novel app can help doctors make better decisions for patients with leukemia.

Triple BNT162b2 vaccination found to establish long-term T lymphocyte immunity among MDS and CLL patients

Triple BNT162b2 vaccination found to establish long-term T lymphocyte immunity among MDS and CLL patients